Thursday, December 21, 2006 8:00:00 AM PDT | VentureDeal Staff
PITTSBURGH, PA -- RedPath Integrated Pathology announced the closing of a series A round of financing totaling $6.5 million. Investors in the round included Seneca Health Partners, Inflexion Partners, HMA Capital Partners, New Spring Capital and CID Capital. RedPath is a national specialty laboratory that provides complex cancer testing services. The company intends to use the funds to increase its sales and marketing efforts and scale its operations.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
